Abstract
IntroductionCerebral venous thrombosis (CVT) accounts for approximately 0.5–1% of all strokes. Current treatment for CVT is consensus guided, with unfractionated or low-molecular-weight heparin recommended in the acute management. The role...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
